205 related articles for article (PubMed ID: 34234779)
21. Mini-Factor H Modulates Complement-Dependent IL-6 and IL-10 Release in an Immune Cell Culture (PBMC) Model: Potential Benefits Against Cytokine Storm.
Kozma GT; Mészáros T; Bakos T; Hennies M; Bencze D; Uzonyi B; Győrffy B; Cedrone E; Dobrovolskaia MA; Józsi M; Szebeni J
Front Immunol; 2021; 12():642860. PubMed ID: 33995361
[TBL] [Abstract][Full Text] [Related]
22. COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel.
Napodano C; Pocino K; Stefanile A; Marino M; Miele L; Gulli F; Basile V; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Scand J Immunol; 2021 Mar; 93(3):e12977. PubMed ID: 32931622
[TBL] [Abstract][Full Text] [Related]
23. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
Yang MC; Tsai CC; Su YT; Wu JR
Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
[No Abstract] [Full Text] [Related]
24. Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection-Implications for Therapeutic Monitoring and Therapeutic Targets.
Drewett GP; Copaescu A; Mouhtouris E; Hannan N; James F; Smibert O; Holmes NE; Trubiano JA
J Clin Immunol; 2021 Aug; 41(6):1162-1164. PubMed ID: 33864183
[No Abstract] [Full Text] [Related]
25. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
[TBL] [Abstract][Full Text] [Related]
26. A Cytokine/Bradykinin Storm Comparison: What Is the Relationship Between Hypertension and COVID-19?
Wilczynski SA; Wenceslau CF; McCarthy CG; Webb RC
Am J Hypertens; 2021 Apr; 34(4):304-306. PubMed ID: 33877321
[No Abstract] [Full Text] [Related]
27. RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota.
Liu T; Wu J; Han C; Gong Z; Regina G; Chen J; Dou F; Silvestri R; Chen C; Yu Z
Int J Biol Sci; 2021; 17(13):3305-3319. PubMed ID: 34512148
[TBL] [Abstract][Full Text] [Related]
28. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
De Toma I; Dierssen M
Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
[TBL] [Abstract][Full Text] [Related]
29. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
30. Immune status could determine efficacy of COVID-19 therapies.
Cully M
Nat Rev Drug Discov; 2020 Jul; 19(7):431-434. PubMed ID: 32546768
[No Abstract] [Full Text] [Related]
31. Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications.
Xiao N; Nie M; Pang H; Wang B; Hu J; Meng X; Li K; Ran X; Long Q; Deng H; Chen N; Li S; Tang N; Huang A; Hu Z
Nat Commun; 2021 Mar; 12(1):1618. PubMed ID: 33712622
[TBL] [Abstract][Full Text] [Related]
32. Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection.
Rutigliani M; Bozzo M; Barberis A; Greppi M; Anelli E; Castellaro L; Bonsignore A; Azzinnaro A; Pesce S; Filauro M; Rollandi GA; Castagnola P; Candiani S; Marcenaro E
Front Immunol; 2022; 13():849140. PubMed ID: 35222440
[TBL] [Abstract][Full Text] [Related]
33. Des-Arg9 bradykinin and bradykinin potentially trigger cytokine storm in patients with COVID-19.
Alikhani M; Javadi A; Aalikhani M
Iran J Immunol; 2021 Mar; 18(1):93-94. PubMed ID: 33787518
[No Abstract] [Full Text] [Related]
34. Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19.
Regidor PA; Santos FG; Rizo JM; Egea FM
Med Hypotheses; 2020 Dec; 145():110340. PubMed ID: 33069094
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-17A (IL-17A): A silent amplifier of COVID-19.
Maione F; Casillo GM; Raucci F; Salvatore C; Ambrosini G; Costa L; Scarpa R; Caso F; Bucci M
Biomed Pharmacother; 2021 Oct; 142():111980. PubMed ID: 34364043
[TBL] [Abstract][Full Text] [Related]
36. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
Ahmed F; Jo DH; Lee SH
Front Immunol; 2020; 11():586765. PubMed ID: 33365027
[No Abstract] [Full Text] [Related]
37. Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2.
Chukwuma IF; Apeh VO; Chiletugo OF
Acta Virol; 2021; 65(1):3-9. PubMed ID: 33112637
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity.
Petruk G; Puthia M; Petrlova J; Samsudin F; Strömdahl AC; Cerps S; Uller L; Kjellström S; Bond PJ; Schmidtchen AA
J Mol Cell Biol; 2020 Oct; 12(12):916-932. PubMed ID: 33295606
[TBL] [Abstract][Full Text] [Related]
39. Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm.
Zhang J; Wu H; Yao X; Zhang D; Zhou Y; Fu B; Wang W; Li H; Wang Z; Hu Z; Ren Y; Sun R; Tian Z; Bian X; Wei H
Cell Mol Immunol; 2021 May; 18(5):1305-1307. PubMed ID: 33742186
[No Abstract] [Full Text] [Related]
40. The Novel Coronavirus and Inflammation.
George JA; Mayne ES
Adv Exp Med Biol; 2021; 1321():127-138. PubMed ID: 33656719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
